Related Posts
Immutep (ASX:IMM) receives fast track designation from FDA
12 Oct 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the FDA fast track designation received in first-line non-small cell lung cancer, the company's new Phase 2 trial in soft tissue sarcoma and the outlook ahead.
Read More
Traxys discusses trends in commodities
01 Nov 2023 - Traxys CEO Mark Kristoff discusses the commodities market and key drivers of change.
Read More
Immutep (ASX:IMM) reports positive discussions with the FDA and strong survival data
19 May 2023 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the significance of recent announcements on the back of a surge in trading volume.
Read More
Immutep (ASX:IMM) announces encouraging trial data for lung cancer therapy
30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses encouraging results in second-line non-small cell lung cancer.
Read More
LBT Innovations (ASX:LBT) receives purchase order for multiple APAS instruments
16 Mar 2022 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discuses the company's recent sales win and its distribution agreement with distributor Thermo Fisher Scientific.
Read More
East 33 (ASX:E33) to list on ASX
27 Nov 2020 - East 33 Limited (ASX:E33) Co-founder and Executive Chairman James Garton talks about the company's dominant position as a supplier and distributor of Sydney Rock Oysters, ambitions ahead of its listing on the ASX and the potential of the world-class Sydney Rock Oyster as a luxury food alongside French Champagne or Beluga Caviar.
Read More
Beyond lithium: Altech’s alternative battery technology for safer storage
26 Mar 2025 - The pros and cons of lithium and CERENERGY grid storage batteries
Read More
The political tailwinds driving European lithium development
31 May 2023 - European Metal Holdings Limited (ASX:EMH) Executive Chairman Keith Coughlan discusses the European demand for lithium and the scale of the company's Cinovec project.
Read More
Novatti Group (ASX:NOV) discusses stablecoin and blockchain technology
19 Apr 2022 - Novatti Group Limited (ASX:NOV) CEO and Managing Director Peter Cook discusses innovations in the payment space, strategy and outlook.
Read More
Market update with Shaw and Partners, March 2021
24 Mar 2021 - Shaw and Partners Chief Investment Officer Martin Crabb discusses historical precedence for recovering from government spending, the possible rise of interest rates, labour market data, and investment strategies in this environment.
Read More